Skip to main content

Advertisement

Log in

Revaluation of the association between vascular endothelial growth factor gene 936 C/T polymorphism and breast cancer risk

  • Letter to the Editor
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Yang DS, Park KH, Woo OH, Woo SU, Kim AR, Lee ES, Lee JB, Kim YH, Kim JS, Seo JH (2011) Association of a vascular endothelial growth factor gene 936 C/T polymorphism with breast cancer risk: a meta-analysis. Breast Cancer Res Treat 125(3):849–853

    Article  PubMed  CAS  Google Scholar 

  2. Boccia S, De Feo E, Gallì P, Gianfagna F, Amore R, Ricciardi G (2010) A systematic review evaluating the methodological aspects of meta-analyses of genetic association studies in cancer research. Eur J Epidemiol 25:765–775

    Article  PubMed  Google Scholar 

  3. Lin GT, Tseng HF, Yang CH, Hou MF, Chuang LY, Tai HT, Tai MH, Cheng YH, Wen CH, Liu CS, Huang CJ, Wang CL, Chang HW (2009) Combinational polymorphisms of seven CXCL12-related genes are protective against breast cancer in Taiwan. OMICS 13(2):165–172

    Article  PubMed  CAS  Google Scholar 

  4. Jacobs EJ, Feigelson HS, Bain EB, Brady KA, Rodriguez C, Stevens VL, Patel AV, Thun MJ, Calle EE (2006) Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort. Breast Cancer Res 8:R22

    Article  PubMed  Google Scholar 

  5. Krippl P, Langsenlehner U, Renner W, Yazdani-Biuki B, Wolf G, Wascher TC, Paulweber B, Haas J, Samonigg H (2003) A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. Int J Cancer 106:468–471

    Article  PubMed  CAS  Google Scholar 

  6. Jin Q, Hemminki K, Enquist K, Lenner P, Grzybowska E, Klaes R, Henriksson R, Chen B, Pamula J, Pekala W, Zientek H, Rogozinska-Szczepka J, Utracka-Hutka B, Hallmans G, Forsti A (2005) Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Clin Cancer Res 11:3647–3653

    Article  PubMed  CAS  Google Scholar 

  7. Jakubowska A, Gronwald J, Menkiszak J, Gorski B, Huzarski T, Byrski T, Edler L, Lubinski J, Scott RJ, Hamann U (2008) The VEGF_936_C[T 30UTR polymorphism reduces BRCA1-associated breast cancer risk in Polish women. Cancer Lett 262:71–76

    Article  PubMed  CAS  Google Scholar 

  8. Kataoka N, Cai Q, Wen W, Shu XO, Jin F, Gao YT, Zheng W (2006) Population-based case–control study of VEGF gene polymorphisms and breast cancer risk among Chinese women. Cancer Epidemiol Biomarkers Prev 15:1148–1152

    Article  Google Scholar 

  9. Balasubramanian SP, Cox A, Cross SS, Higham SE, Brown NJ, Reed MW (2007) Influence of VEGF-A gene variation and protein levels in breast cancer susceptibility and severity. Int J Cancer 121:1009–1016

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

This study was supported by Zhejiang Provincial Natural Science Foundation of China (project no.: Y206776).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zhishan Ding.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jin, B., Jiang, F. & Ding, Z. Revaluation of the association between vascular endothelial growth factor gene 936 C/T polymorphism and breast cancer risk. Breast Cancer Res Treat 128, 909–912 (2011). https://doi.org/10.1007/s10549-011-1439-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-011-1439-9

Keywords

Navigation